Specifically, given the role of the HLA-DRB1*1501 in MS susceptibility (4, 22, 37), it was interesting to detect the impact of HLA-DRB1*1501 on CD4+ clonal expansion (Figure 2B). This evidence concerns the gene CD4 and myeloid sarcoma.